Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05282)

• Formulation Name: Deferasirox 90 mg tablet
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Exjade	(DMHPRWG)	Iron overload disease	5C64.10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent